Clarus Ventures

Portfolio · 1

Tisbury Pharmaceuticals

Open-angle Glaucoma Treatment

1 round $32.0M committed Latest: 2017-06

Investment activity

Q&A

What is Clarus Ventures' primary investment focus?

Clarus Ventures primarily focuses on the Health Tech & Life Sciences sector, as evidenced by its portfolio company Tisbury Pharmaceuticals.

Can you name a notable portfolio company for Clarus Ventures?

A notable portfolio company for Clarus Ventures is Tisbury Pharmaceuticals, which develops treatments for open-angle glaucoma.

What is the most recent investment round Clarus Ventures participated in?

Clarus Ventures participated in a Series A round for Tisbury Pharmaceuticals in June 2017, which raised $32M.

What is Clarus Ventures' typical investment stage?

Clarus Ventures has participated in Series A rounds, such as the $32M investment in Tisbury Pharmaceuticals.

What is the typical check size for Clarus Ventures?

Clarus Ventures' investment range is $32M, based on its participation in the Series A round for Tisbury Pharmaceuticals.